|
Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System
|
4R44CA195831-02
|
$843,368
|
|
KHACHATURIAN, MARK
|
ABT MOLECULAR IMAGING, INC.
|
|
Hybridoma-free multiplex approach for accelerating mouse monoclonal antibody generation
|
3R43CA193101-01S1
|
$39,966
|
|
TRAN, HIEP
|
ABZYME THERAPEUTICS, LLC
|
|
Targeting B-cell lymphoma with Leukothera-phase II
|
3R42CA173900-03S1
|
$140,000
|
|
BELINKA, BENJAMIN
|
ACTINOBAC BIOMED, INC.
|
|
Peptide-based slides for improving the diagnostic quality of sputum specimens
|
1R43CA206675-01A1
|
$299,999
|
|
DARBY, MARTYN
|
AFFINERGY, LLC
|
|
Development of immuno-PET agents for the selective imaging of CD8 T cells
|
1R43CA210714-01A1
|
$300,000
|
|
GOSTISSA, MONICA
|
AGENUS, INC.
|
|
IAA BETWEEN NCI/DCCPS/HDRP/HARB AND AHRQ-MEPS. PERIOD OF PERFORMANCE 6/24/2016 THROUGH 9/30/2017. $325,040, HARB FMP, $100K OBSSR= $425,040 TOTAL. LINDA C. HARLAN, COR.
|
APC16009001
|
$386,046
|
|
UNKNOWN, UNKNOWN
|
AHRQ - AGENCY FOR HEALTHCARE RESEARCH & QUALI
|
|
OPTION PERIOD 1: PATIENT ACCRUAL AND TREATMENT 12/30/2015-12/29/2016
|
261201500022C
|
$445,512
|
|
UNKNOWN, UNKNOWN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
|
5R01CA178394-03
|
$346,525
|
|
GAVATHIOTIS, EVRIPIDIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
1F30CA210539-01
|
$43,576
|
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-05
|
$439,400
|
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Exhaled microRNAs leveraged for lung cancer risk assessment
|
5R21CA192168-03
|
$181,613
|
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
1F30CA203446-01A1
|
$43,576
|
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
5R01CA191077-02
|
$312,244
|
|
NAPPER, ANDREW
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays
|
1R43CA203647-01A1
|
$225,000
|
|
LIM, MARK
|
AMBERGEN, INC
|
|
Ninth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA210546-01
|
$74,000
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Young Minority Scientists in the Field of Cancer
|
2R13CA040577-30
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
MSI Faculty in the Field of Cancer Research
|
2R13CA076526-19
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
5R42CA153845-03
|
$772,615
|
$772,615
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
1U01CA214201-01
|
$480,733
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
OPTION YEAR 2 - APPLICATION SUPPORT -- QTY OF 1 @ $597,935.00
|
261201500033I
|
$1,999,910
|
|
UNKNOWN, UNKNOWN
|
ARTIFICIAL INTELLIGENCE IN MEDICINE, INC
|
|
PNNL Clinical Proteome Characterization Center
|
3U24CA160019-05S1
|
$1,170,366
|
|
SMITH, RICHARD
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
NEXT NX157-110-187-004 TO#17 TOX STUDY OF 5-AZA-TDCYD IN BEAGEL DOGS, 1/15-6/30/16, PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER OTHER DISEASES HHSN261201100019 TPB
|
261201100019C
|
$60,052
|
|
UNKNOWN, UNKNOWN
|
BATTELLE SEATTLE RESEARCH CENTER
|
|
Consortium for large-scale production and phenotyping of knockout mice (UM1)
|
2UM1HG006348-06
|
$1,260,000
|
|
BEAUDET, ARTHUR
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$371,719
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$1,183
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$1,223
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
ESTABLISHING A CONDITIONAL TELOMERASE KNOCK-IN ALLELE IN A HAPLOID CANCER CELL LINE TO IDENTIFY REGULATORS OF ALT THROUGH GENETIC FORWARD SCREENS
|
1R21CA198701-01A1
|
$206,843
|
|
SAHIN, ERGUN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
1R50CA211280-01
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-16
|
$539,228
|
$539,228
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$9,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
1R21CA205106-01A1
|
$234,992
|
$234,992
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
$54,399
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$2,199
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$3,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$73,400
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cellular and Molecular Properties of PINs in Prostate Tumorigenesis
|
7R21CA190021-03
|
$221,787
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers
|
1R50CA211397-01
|
$282,253
|
|
ZHENG, LI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
7R01CA185137-03
|
$918,872
|
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of extracellular matrix mediated drug resistance
|
4R00CA180221-03
|
$248,999
|
|
MURANEN, TARU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
|
1R01CA210360-01
|
$676,510
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Boston University-UCLA Lung Cancer Biomarker Development Lab
|
1U01CA214182-01
|
$565,669
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Planning for NCDs Research Center of Excellence in Southern Africa
|
1P20CA210283-01
|
$239,055
|
|
TAPELA, NEO
|
BOTSWANA-HARVARD AIDS INSTITUTE
|
|
Oncogenic Notch Signaling
|
3P01CA119070-10S1
|
$58,609
|
|
ASTER, JON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-03
|
$377,464
|
$377,464
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
|
1R35CA197605-01
|
$1,052,893
|
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Studying the Role of Aneuploidy in Cancer Immune Evasion
|
1K99CA212621-01
|
$137,124
|
|
DAVOLI, TERESA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Herpes - Other for this search: $53,584,332
|